Court Ruling Casts Long Shadow Over Future Opioid Lawsuits

May 31, 2023

(Axios) – A federal appeals court on Tuesday potentially laid the groundwork for corporations to avoid legal exposure in future opioid lawsuits through a technicality in bankruptcy law. Driving the news: The New York-based 2nd U.S. Circuit Court of Appeals ruled that, as part of a proposed bankruptcy settlement, members of the Sackler family who own OxyContin maker Purdue Pharma could be shielded from current and future civil claims in exchange for paying up to $6 billion and giving up control of the company. (Read More)